Trial no.:
|
PACTR201703002083424 |
Date of Approval:
|
08/03/2017 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Magnesium sulphate as an adjuvant to levobupivacaine for post-operative analgesia in lower abdominal and pelvic surgeries under epidural anesthesia (R |
Official scientific title |
Magnesium sulphate as an adjuvant to levobupivacaine for post-operative analgesia in lower abdominal and pelvic surgeries under epidural anesthesia (RCT) |
Brief summary describing the background
and objectives of the trial
|
Epidural analgesia for postoperative pain management is considered a critical component of multimodal approach to achieve adequate analgesia with improved outcome. Levobupivacaine has a lower risk profile of toxicity regarding cardiovascular and central nervous systems than bupivacaine.
Magnesium, as an adjuvant, has been used with local anesthetics for prolongation of postoperative epidural and intrathecal analgesia.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia,postoperative pain |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
02/08/2014 |
Actual trial start date |
27/08/2014 |
Anticipated date of last follow up |
01/09/2015 |
Actual Last follow-up date |
27/10/2015 |
Anticipated target sample size (number of participants) |
100 |
Actual target sample size (number of participants) |
100 |
Recruitment status |
Completed |
Publication URL |
Magnesium sulphate as an adjuvant to levobupivacaine for post-operative analgesia in lower abdominal and pelvic surgeries under epidural anesthesia (RCT) |
|